logotipo da Pluricell
ícone de coração com linha representando frequencia cardíaca
Heart failure affects 26 million people worldwide
ícone de custos hospitalares
The costs associated with Heart Failure exceed 100 billion dollars a year

Did you know?

Context
ícones de mãos em volta de simbolo médico
Rett syndrome is a genetic disease that has no definitive treatment
ícone de quebra-cabeças
Rett Syndrome is a disease of the autistic spectrum

Cell therapies

What we do

PluriCell Biotech is a startup that develops cell therapies based on pluripotent stem cells. We are currently focused on developing therapies for patients with heart and neurological problems. More specifically, congestive heart failure (CHF) and Rett syndrome. We believe that cell therapy is the future of regenerative medicine.

We have prepared a short video to explain what we do!

Pluricell Team

Marcos Valadares
Marcos Valadares
CEO
Diogo Biagi
Diogo Biagi
CSO
Estela Cruvinel
Estela Cruvinel
Principal Investigator
Rafael Dariolli
Rafael Dariolli
Principal Investigator (Pre-Clinical Tests)
Sofia Ramos
Sofia Ramos
Cell Culture Coordinator
Antônio Ribeiro
Antônio Ribeiro
Pre-Clinical Researcher
Julliana Carvalho
Julliana Carvalho
Pre-Clinical Researcher
Sirlene Rodrigues
Sirlene Rodrigues
Junior Researcher
Renato Leite
Renato Leite
Admin Staff
flecha para a esquerdaflecha para a direita

Pipeline

Currently, PluriCell is focused on solving problems in two specific diseases, namely: Heart Failure through the use of cardiac cells and Rett Syndrome with the use of healthy astrocytes, both of the cells produced in the laboratory. In the future, we plan to expand our operations to other areas such as ophthalmology, endocrinology and etc., always producing authentic human cells on a scale.
DISEASE
CELL TYPE
RESEARCH
POC PRE-
CLINICAL
IND ENABLIGN
TESTS
PH 1/2
Heart failure
Cardiomyocytes
Today
Q4/2023
Q1/2026
Q4/2027
Rett Syndrome
Astrocytes
Today
Q4/2023
Q4/2027

Contact us through the channels below, or fill out the form:

Marcos Valadares
Marcos Valadares
CEO
Marcos has a major in Biology and a doctorate in human genetics and stem cells by the Biosciences Institute of the University of São Paulo. He has recently finished an MBA in Management of Health innovation by the Butantan Institute, São Paulo and has a strong interest in contributing for the growth of biotech entrepreneurship environment in Brazil.
Diogo Biagi
Diogo Biagi
CSO
Diogo has a major in Biology and a masters and doctorate in human genetics and stem cells by the Heart Institute of the Medical School in University of São Paulo.
Estela Cruvinel
Estela Cruvinel
Principal Investigator
Estela has a major in Biology and a masters and doctorate in human genetics and stem cells by the Biosciences Institute of the University of São Paulo.
Rafael Dariolli
Rafael Dariolli
Principal Investigator (Pre-Clinical Tests)
Rafael is a biologist graduated from UNESP with master’s and PhD from the Heart Institute of USP with more than 10 years of hands on experience in animal tests.
Sofia Ramos
Sofia Ramos
Cell Culture Coordinator
Sofia is a Biologist and has a master degree in human genetics and stem cells by the Biosciences Institute of the University of São Paulo. Has experience in molecular biology techniques and stem cell cultivation.
Antônio Ribeiro
Antônio Ribeiro
Pre-Clinical Researcher
Antonio is a biologist from Paulista University with a master and doctor degree in human genetics from the Bioscience Institute, University of São Paulo. He has experience in histology and molecular biology, having worked with muscle regeneration in animal models
Julliana Carvalho
Julliana Carvalho
Pre-Clinical Researcher
Julliana has a major in Biomedicine and doctorate degree in Medical Science and Cardiology by the Heart Institute of the Medical School in University of São Paulo.
Sirlene Rodrigues
Sirlene Rodrigues
Junior Researcher
Sirlene graduated in Biology from the Institute of Biological Sciences from the University of São Paulo with emphasis in cell culture.
Renato Leite
Renato Leite
Admin Staff
Renato is an engineer from University of Minas Gerais with experience inventory management
cross